Inhibition of viral replication by mutants of the duck hepatitis B virus core protein Department of Medicine, University Hospital Freiburg, Germany

Hepatology ◽  
1995 ◽  
Vol 22 (4) ◽  
pp. A268
Hepatology ◽  
1999 ◽  
Vol 30 (1) ◽  
pp. 308-315 ◽  
Author(s):  
Fritz von Weizsäcker ◽  
Josef Köck ◽  
Stefan Wieland ◽  
Wolf-Bernhard Offensperger ◽  
Hubert E. Blum

Virology ◽  
2006 ◽  
Vol 353 (2) ◽  
pp. 443-450 ◽  
Author(s):  
Haitao Guo ◽  
Carol E. Aldrich ◽  
Jeffry Saputelli ◽  
Chunxiao Xu ◽  
William S. Mason

2003 ◽  
Vol 278 (30) ◽  
pp. 28123-28129 ◽  
Author(s):  
Josef Köck ◽  
Michael Kann ◽  
Gerhard Pütz ◽  
Hubert E. Blum ◽  
Fritz von Weizsäcker

2007 ◽  
Vol 81 (23) ◽  
pp. 13230-13234 ◽  
Author(s):  
Jolanta Vorreiter ◽  
Immanuel Leifer ◽  
Christine Rösler ◽  
Ludmila Jackevica ◽  
Paul Pumpens ◽  
...  

ABSTRACT The icosahedral capsid of duck hepatitis B virus (DHBV) is formed by a single core protein species (DHBc). DHBc is much larger than HBc from human HBV, and no high-resolution structure is available. In an accompanying study (M. Nassal, I. Leifer, I. Wingert, K. Dallmeier, S. Prinz, and J. Vorreiter, J. Virol. 81:13218-13229, 2007), we used extensive mutagenesis to derive a structural model for DHBc. For independent validation, we here mapped the epitopes of seven anti-DHBc monoclonal antibodies. Using numerous recombinant DHBc proteins and authentic nucleocapsids from different avihepadnaviruses as test antigens, plus a panel of complementary assays, particle-specific and exposed plus buried linear epitopes were revealed. These data fully support key features of the model.


Hepatology ◽  
2002 ◽  
Vol 35 (1) ◽  
pp. 209-216 ◽  
Author(s):  
Fritz von Weizsäcker ◽  
Josef Köck ◽  
Stefan Wieland ◽  
Jürgen Beck ◽  
Michael Nassal ◽  
...  

2005 ◽  
Vol 79 (19) ◽  
pp. 12242-12252 ◽  
Author(s):  
Marc F. Le Mire ◽  
Darren S. Miller ◽  
Wendy K. Foster ◽  
Christopher J. Burrell ◽  
Allison R. Jilbert

ABSTRACT Residual hepatitis B virus (HBV) DNA can be detected in serum and liver after apparent recovery from transient infection. However, it is not known if this residual HBV DNA represents ongoing viral replication and antigen expression. In the current study, ducks inoculated with duck hepatitis B virus (DHBV) were monitored for residual DHBV DNA following recovery from transient infection until 9 months postinoculation (p.i.). Resolution of DHBV infection occurred in 13 out of 15 ducks by 1-month p.i., defined as clearance of DHBV surface antigen-positive hepatocytes from the liver and development of anti-DHBV surface antibodies. At 9 months p.i., residual DHBV DNA was detected using nested PCR in 10/11 liver, 7/11 spleen, 2/11 kidney, 1/11 heart, and 1/11 adrenal samples. Residual DHBV DNA was not detected in serum or peripheral blood mononuclear cells. Within the liver, levels of residual DHBV DNA were 0.0024 to 0.016 copies per cell, 40 to 80% of which were identified as covalently closed circular viral DNA by quantitative PCR assay. This result, which was confirmed by Southern blot hybridization, is consistent with suppressed viral replication or inactive infection. Samples of liver and spleen cells from recovered animals did not transmit DHBV infection when inoculated into 1- to 2-day-old ducklings, and immunosuppressive treatment of ducks with cyclosporine and dexamethasone for 4 weeks did not alter levels of residual DHBV DNA in the liver. These findings further characterize a second form of hepadnavirus persistence in a suppressed or inactive state, quite distinct from the classical chronic carrier state.


Sign in / Sign up

Export Citation Format

Share Document